Downregulation of CRKL expression can inhibit tumorigenesis in colon cancer

Frontiers in Bioscience - Landmark

Volumn 19, Issue 3, 2014, Pages 528-534

  Lan, Bin ^a   Zhang, Jian ^a   Shan, Jingxuan ^b   Zhang, Peng ^c   Zhang, Weihong ^a   Chen, Yanchao ^a   Zhen, Wei ^a   Yan, Shugang ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^c SHANGHAI PULMONARY HOSPITAL   (China)

Author keywords

Apoptosis; Cell growth; Colon cancer cells; CRKL; Invasion; Migration

Indexed keywords

CRK LIKE PROTEIN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL; ARTICLE; CARCINOGENESIS; COLON TUMOR; DOWN REGULATION; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CARCINOGENESIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; NUCLEAR PROTEINS;

EID: 84904302192     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4223     Document Type: Article

References (25)

1. S. M. Feller: Crk family adaptors-signalling complex formation and biological roles. Oncogene, 20(44), 6348-71 (2001)
2. J. Rhodes, R. D. York, D. Tara, K. Tajinda and B. J. Druker: CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells. Exp Hematol, 28(3), 305-10 (2000)
3. N. Uemura and J. D. Griffin: The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration. J Biol Chem, 274(53), 37525-32 (1999)
4. A. M. Teckchandani, E. A. Feshchenko and A. Y. Tsygankov: c-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases. Oncogene, 20(14), 1739-55 (2001)
5. C. A. Moore, C. A. Parkin, Y. Bidet and P. W. Ingham: A role for the Myoblast city homologues Dock1 and Dock5 and the adaptor proteins Crk and Crk-like in zebrafish myoblast fusion. Development, 134(17), 3145-53 (2007)
6. J. F. Dorsey, R. Jove, A. J. Kraker and J. Wu: The pyrido[2,3-d] pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells. Cancer Res, 60(12), 3127-31 (2000)
7. K. E. Fathers, E. S. Bell, C. V. Rajadurai, S. Cory, H. Zhao, A. Mourskaia, D. Zuo, J. Madore, A. Monast, A. M. Mes-Masson, A. A. Grosset, L. Gaboury, M. Hallet, P. Siegel and M. Park: Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Breast Cancer Res, 14(3), R74 (2012)
8. R. A. Padmanabhan, L. Nirmala, M. Murali and M. Laloraya: CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer. Mol Endocrinol, 25(9), 1499-512 (2011)
9. K. E. Fathers, S. Rodrigues, D. Zuo, I. V. Murthy, M. Hallett, R. Cardiff and M. Park: CrkII transgene induces atypical mammary gland development and tumorigenesis. Am J Pathol, 176(1), 446-60 (2010)
10. J. Wang, Y. L. Che, G. Li, B. Liu, T. M. Shen, H. Wang and H. Linghu: Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma. Mol Carcinog, 50(7), 506-15 (2011)
11. Y. Wang, Q. Z. Dong, L. Fu, M. Stoecker, E. Wang and E. H. Wang: Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer. Mol Carcinog (2012)
12. H. Natsume, K. Shinmura, H. Tao, H. Igarashi, M. Suzuki, K. Nagura, M. Goto, H. Yamada, M. Maeda, H. Konno, S. Nakamura and H. Sugimura: The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer. J Transl Med, 10, 97 (2012)
13. H. Yanagi, L. Wang, H. Nishihara, T. Kimura, M. Tanino, T. Yanagi, S. Fukuda and S. Tanaka: CRKL plays a pivotal role in tumorigenesis of head and neck squamous cell carcinoma through the regulation of cell adhesion. Biochem Biophys Res Commun, 418(1), 104-9 (2012)
14. H. Nishihara, S. Tanaka, M. Tsuda, S. Oikawa, M. Maeda, M. Shimizu, H. Shinomiya, A. Tanigami, H. Sawa and K. Nagashima: Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett, 180(1), 55-61 (2002)
15. R. Beroukhim, C. H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J. S. Boehm, J. Dobson, M. Urashima, K. T. Mc Henry, R. M. Pinchback, A. H. Ligon, Y. J. Cho, L. Haery, H. Greulich, M. Reich, W. Winckler, M. S. Lawrence, B. A. Weir, K. E. Tanaka, D. Y. Chiang, A. J. Bass, A. Loo, C. Hoffman, J. Prensner, T. Liefeld, Q. Gao, D. Yecies, S. Signoretti, E. Maher, F. J. Kaye, H. Sasaki, J. E. Tepper, J. A. Fletcher, J. Tabernero, J. Baselga, M. S. Tsao, F. Demichelis, M. A. Rubin, P. A. Janne, M. J. Daly, C. Nucera, R. L. Levine, B. L. Ebert, S. Gabriel, A. K. Rustgi, C. R. Antonescu, M. Ladanyi, A. Letai, L. A. Garraway, M. Loda, D. G. Beer, L. D. True, A. Okamoto, S. L. Pomeroy, S. Singer, T. R. Golub, E. S. Lander, G. Getz, W. R. Sellers and M. Meyerson: The landscape of somatic copy-number alteration across human cancers. Nature, 463(7283), 899-905 (2010)
16. C. Jiang, X. P. Yi, H. Shen and Y. X. Li: Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. World J Gastroenterol, 18(23), 2956-65 (2012)
17. X. T. Wang, Y. B. Xie and Q. Xiao: siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells. World J Gastroenterol, 18(16), 1903-14 (2012)
18. A. Fernandez-Medarde and E. Santos: Ras in cancer and developmental diseases. Genes Cancer, 2(3), 344-58 (2011)
19. Z. Wang, H. Jin, R. Xu, Q. Mei and D. Fan: Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med, 41(10), 717-27 (2009)
20. D. Wang, J. Chen, H. Chen, Z. Duan, Q. Xu, M. Wei, L. Wang and M. Zhong: Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway. J Biosci, 37(1), 91-101 (2012)
21. V. Reebye, A. Frilling, N. A. Habib and P. J. Mintz: Intracellular adaptor molecules and AR signalling in the tumour microenvironment. Cell Signal, 23(6), 1017-21 (2011)
22. P. J. Mintz, M. Cardo-Vila, M. G. Ozawa, A. Hajitou, R. Rangel, L. Guzman-Rojas, D. R. Christianson, M. A. Arap, R. J. Giordano, G. R. Souza, J. Easley, A. Salameh, S. Oliviero, R. R. Brentani, E. Koivunen, W. Arap and R. Pasqualini: An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment. Proc Natl Acad Sci U S A, 106(7), 2182-7 (2009)
23. T. Motiwala, S. Majumder, K. Ghoshal, H. Kutay, J. Datta, S. Roy, D. M. Lucas and S. T. Jacob: PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells. J Biol Chem, 284(1), 455-64 (2009)
24. L. Q. Liu, Z. L. Liu, X. Wang, H. Y. Cui, M. D. Jin, D. Y. Wang and S. A. Huang: [Mechanism of cinnamic aldehyde-inducing apoptosis of chronic myeloid leukemic cells in vitro]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 19(3), 617-20 (2011)
25. A. Hamilton, G. V. Helgason, M. Schemionek, B. Zhang, S. Myssina, E. K. Allan, F. E. Nicolini, C. Muller-Tidow, R. Bhatia, V. G. Brunton, S. Koschmieder and T. L. Holyoake: Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood, 119(6), 1501-10 (2012)